This study also corroborates evidence for individual candidate biomarkers of high-risk IPMN, including CD55, laminin subunit gamma 2 (LAMC2), amphiregulin (AREG), and others. Here, CD55 is linked to pancreatic intraductal papillary-mucinous neoplasm.